Literature DB >> 12206853

Modulation of formalin-induced behaviors and edema by local and systemic administration of dextromethorphan, memantine and ketamine.

Jana Sawynok1, Allison Reid.   

Abstract

The present study examined the effects of local peripheral and systemic administration of three clinically used excitatory amino acid receptor antagonists (dextromethorphan, memantine, ketamine) on pain behaviors and edema produced by formalin (1.5% and 5%) in rats. Peripheral administration of dextromethorphan produced a locally mediated suppression of flinching behaviors induced by 1.5% and 5% formalin, but biting/licking behaviors were not affected. Memantine and ketamine had no effect on either of these behaviors. All three agents augmented edema produced by 1.5% and 5% formalin. When administered alone, dextromethorphan, memantine and ketamine produced an intrinsic paw swelling response, and this was blocked by the biogenic amine receptor antagonists mepyramine, phentolamine, methysergide and ketanserin. Following systemic administration, all three agents suppressed biting/licking behaviors, had no effect on flinching behaviors, and suppressed paw swelling induced by 5% formalin to varying degrees. These results provide evidence for a peripherally mediated antinociceptive action of dextromethorphan in the rat formalin test, but this may not necessarily be due to block of excitatory amino acid receptors as it is not observed with memantine or ketamine. All three agents produce a peripherally mediated paw swelling, which is likely due to blockade of biogenic amine reuptake. Systemic administration of all three agents produces antinociceptive and anti-inflammatory actions that may be due to block of excitatory amino acid receptors in the spinal cord. Copyright 2002 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12206853     DOI: 10.1016/s0014-2999(02)02119-2

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  13 in total

1.  Antioxidant, antinociceptive and anti-inflammatory activities of atorvastatin and rosuvastatin in various experimental models.

Authors:  Mahesh M Ghaisas; Prasad R Dandawate; Suyash A Zawar; Yogesh S Ahire; Santosh P Gandhi
Journal:  Inflammopharmacology       Date:  2010-06-08       Impact factor: 4.473

2.  A single subanesthetic dose of ketamine relieves depression-like behaviors induced by neuropathic pain in rats.

Authors:  Jing Wang; Yossef Goffer; Duo Xu; David S Tukey; D B Shamir; Sarah E Eberle; Anthony H Zou; Thomas J J Blanck; Edward B Ziff
Journal:  Anesthesiology       Date:  2011-10       Impact factor: 7.892

3.  Selective knockdown of NMDA receptors in primary afferent neurons decreases pain during phase 2 of the formalin test.

Authors:  J A McRoberts; H S Ennes; J C G Marvizón; M S Fanselow; E A Mayer; B Vissel
Journal:  Neuroscience       Date:  2010-10-23       Impact factor: 3.590

4.  Effects of the noncompetitive N-methyl-d-aspartate receptor antagonists ketamine and MK-801 on pain-stimulated and pain-depressed behaviour in rats.

Authors:  T M Hillhouse; S S Negus
Journal:  Eur J Pain       Date:  2016-02-23       Impact factor: 3.931

5.  Clinical pharmacy intervention post tonsillectomy: a randomized control trial.

Authors:  Bushra Abdul Hadi; Saleh M Sbeitan
Journal:  Int J Clin Pharm       Date:  2015-01-07

6.  Valproic acid: an anticonvulsant drug with potent antinociceptive and anti-inflammatory properties.

Authors:  José Christian Machado Ximenes; Danilo de Oliveira Gonçalves; Rafaelly Maria Pinheiro Siqueira; Kelly Rose Tavares Neves; Gilberto Santos Cerqueira; Alyne Oliveira Correia; Francisco Hélder Cavalcante Félix; Luzia Kalyne Almeida Moreira Leal; Gerly Anne de Castro Brito; Maria da Graça Naffah-Mazzacorati; Glauce Socorro de Barros Viana
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-04-14       Impact factor: 3.000

7.  Profound swim stress-induced analgesia with ketamine.

Authors:  Asma Hayati Ahmad; Zalina Ismail; Myo Than; Azhar Ahmad
Journal:  Malays J Med Sci       Date:  2008-01

8.  Loss of NR1 subunit of NMDARs in primary sensory neurons leads to hyperexcitability and pain hypersensitivity: involvement of Ca(2+)-activated small conductance potassium channels.

Authors:  Promila Pagadala; Chul-Kyu Park; Sangsu Bang; Zheng-Zhong Xu; Rou-Gang Xie; Tong Liu; Bao-Xia Han; W Daniel Tracey; Fan Wang; Ru-Rong Ji
Journal:  J Neurosci       Date:  2013-08-14       Impact factor: 6.167

9.  Pharmacodynamics of memantine: an update.

Authors:  G Rammes; W Danysz; C G Parsons
Journal:  Curr Neuropharmacol       Date:  2008-03       Impact factor: 7.363

10.  Modulation of formalin-induced fos-like immunoreactivity in the spinal cord by swim stress-induced analgesia, morphine and ketamine.

Authors:  Ahmad Asma Hayati; Ismail Zalina; Than Myo; Abdul Aziz Che Badariah; Ahmad Azhar; Long Idris
Journal:  Ger Med Sci       Date:  2008-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.